Schedule 13D ownership disclosure

REVIVA PHARMACEUTCLS HLDGS I

Security class unavailable · CUSIP: 76152G100

Event date: 2024-08-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,893,914
Percent of class
8.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-24-027667
Form type
SC 13D/A
Filer
Bhat Laxminarayan
CIK
CIK 1818245
Filed
Aug 23, 2024
Reporting period
Aug 22, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub